These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 15568158)
1. Osteopontin expression in ductal adenocarcinomas and undifferentiated carcinomas of the pancreas. Sedivy R; Peters K; Klöppel G Virchows Arch; 2005 Jan; 446(1):41-5. PubMed ID: 15568158 [TBL] [Abstract][Full Text] [Related]
2. Advanced pancreatic ductal cancer: fibrotic focus and beta-catenin expression correlate with outcome. Watanabe I; Hasebe T; Sasaki S; Konishi M; Inoue K; Nakagohri T; Oda T; Mukai K; Kinoshita T Pancreas; 2003 May; 26(4):326-33. PubMed ID: 12717263 [TBL] [Abstract][Full Text] [Related]
3. Osteopontin expression and distribution in human carcinomas. Brown LF; Papadopoulos-Sergiou A; Berse B; Manseau EJ; Tognazzi K; Perruzzi CA; Dvorak HF; Senger DR Am J Pathol; 1994 Sep; 145(3):610-23. PubMed ID: 8080043 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma. Koopmann J; Fedarko NS; Jain A; Maitra A; Iacobuzio-Donahue C; Rahman A; Hruban RH; Yeo CJ; Goggins M Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):487-91. PubMed ID: 15006928 [TBL] [Abstract][Full Text] [Related]
5. Expression of novel markers of pancreatic ductal adenocarcinoma in pancreatic nonductal neoplasms: additional evidence of different genetic pathways. Cao D; Maitra A; Saavedra JA; Klimstra DS; Adsay NV; Hruban RH Mod Pathol; 2005 Jun; 18(6):752-61. PubMed ID: 15696124 [TBL] [Abstract][Full Text] [Related]
6. Expression of E-cadherin and alpha-, beta-, gamma-catenin proteins in endometrial carcinoma. Kim YT; Choi EK; Kim JW; Kim DK; Kim SH; Yang WI Yonsei Med J; 2002 Dec; 43(6):701-11. PubMed ID: 12497652 [TBL] [Abstract][Full Text] [Related]
7. Expression of ICAM-1, E-cadherin, periostin and midkine in metastases of pancreatic ductal adenocarcinomas. Grupp K; Melling N; Bogoevska V; Reeh M; Uzunoglu FG; El Gammal AT; Nentwich MF; Izbicki JR; Bogoevski D Exp Mol Pathol; 2018 Apr; 104(2):109-113. PubMed ID: 29355490 [TBL] [Abstract][Full Text] [Related]
8. [A study of E-cadherin and beta-catenin expression and their correlation with prognosis of nonsmall cell lung carcinoma]. Qiu X; Yang X; Li Q; Wang E Zhonghua Bing Li Xue Za Zhi; 2002 Aug; 31(4):318-21. PubMed ID: 12417088 [TBL] [Abstract][Full Text] [Related]
9. The correlations of LMX1A and osteopontin expression to the clinicopathologic stages in pancreatic adenocarcinoma. Tsai WC; Lin CK; Yang YS; Chan DC; Gao HW; Chang FN; Jin JS Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):395-400. PubMed ID: 23165334 [TBL] [Abstract][Full Text] [Related]
10. Expression pattern of osteopontin in endometrial carcinoma: correlation with expression of the adhesion molecule CEACAM1. Briese J; Schulte HM; Bamberger CM; Löning T; Bamberger AM Int J Gynecol Pathol; 2006 Apr; 25(2):161-9. PubMed ID: 16633066 [TBL] [Abstract][Full Text] [Related]
11. EGFR expression in pancreatic adenocarcinoma. Relationship to tumour morphology and cell adhesion proteins. Handra-Luca A; Hammel P; Sauvanet A; Lesty C; Ruszniewski P; Couvelard A J Clin Pathol; 2014 Apr; 67(4):295-300. PubMed ID: 24170210 [TBL] [Abstract][Full Text] [Related]
12. alpha-, beta- and chi-catenin expression in human pancreatic cancer. Julkunen K; Mäkinen K; Kärjä V; Kosma VM; Eskelinen M Anticancer Res; 2003; 23(6D):5043-7. PubMed ID: 14981965 [TBL] [Abstract][Full Text] [Related]
13. Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer. Pang H; Lu H; Song H; Meng Q; Zhao Y; Liu N; Lan F; Liu Y; Yan S; Dong X; Cai L Cancer Epidemiol; 2013 Dec; 37(6):985-92. PubMed ID: 24012693 [TBL] [Abstract][Full Text] [Related]
14. Paraneoplastic Ma Antigen-Like 1 as a Potential Prognostic Biomarker in Human Pancreatic Ductal Adenocarcinoma. Kuwae Y; Kakehashi A; Wakasa K; Wei M; Yamano S; Ishii N; Ohsawa M; Wanibuchi H Pancreas; 2015 Jan; 44(1):106-15. PubMed ID: 25251443 [TBL] [Abstract][Full Text] [Related]
15. Expression of the E-cadherin-catenin complex in patients with pancreatic ductal adenocarcinoma. Pryczynicz A; Guzińska-Ustymowicz K; Kemona A; Czyzewska J Folia Histochem Cytobiol; 2010 Jan; 48(1):128-33. PubMed ID: 20529828 [TBL] [Abstract][Full Text] [Related]
16. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids. Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207 [TBL] [Abstract][Full Text] [Related]
17. E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma. Bukholm IK; Nesland JM; Kåresen R; Jacobsen U; Børresen-Dale AL J Pathol; 1998 Jul; 185(3):262-6. PubMed ID: 9771479 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the E-cadherin-catenin complexes in pancreatic carcinoma cell lines. El-Hariry I; Jordinson M; Lemoine N; Pignatelli M J Pathol; 1999 Jun; 188(2):155-62. PubMed ID: 10398158 [TBL] [Abstract][Full Text] [Related]
19. Relationship between expressions of E-cadherin and alpha-catenin and biological behaviors of human pancreatic cancer. Li YJ; Meng YX; Ji XR Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):471-7. PubMed ID: 14599963 [TBL] [Abstract][Full Text] [Related]
20. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features. Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]